Jiayi Zeng

741 total citations
22 papers, 486 citations indexed

About

Jiayi Zeng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiayi Zeng has authored 22 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiayi Zeng's work include Ferroptosis and cancer prognosis (5 papers), Renal cell carcinoma treatment (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jiayi Zeng is often cited by papers focused on Ferroptosis and cancer prognosis (5 papers), Renal cell carcinoma treatment (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jiayi Zeng collaborates with scholars based in China, Australia and United States. Jiayi Zeng's co-authors include Zhong Han, Haipeng Zhang, Xiangxue Li, Yuan Lin, Guangmei Yan, Wei Wu, Shicheng Su, Xue Chao, Yandan Yao and Yan Nie and has published in prestigious journals such as Cancer Research, Scientific Reports and International Journal of Cancer.

In The Last Decade

Jiayi Zeng

18 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiayi Zeng China 11 208 192 93 58 53 22 486
Shaoyan Liu China 12 371 1.8× 218 1.1× 113 1.2× 47 0.8× 49 0.9× 43 657
Yumei Pu China 13 270 1.3× 132 0.7× 136 1.5× 26 0.4× 88 1.7× 35 552
Haoyu Guo China 13 387 1.9× 188 1.0× 56 0.6× 31 0.5× 26 0.5× 27 659
Hongbing Zhang China 13 323 1.6× 215 1.1× 130 1.4× 47 0.8× 25 0.5× 46 568
Xiangfu Chen China 16 454 2.2× 231 1.2× 150 1.6× 34 0.6× 29 0.5× 43 705
Jufeng Zhang China 18 402 1.9× 290 1.5× 122 1.3× 43 0.7× 29 0.5× 66 871
Chunjie Xu China 18 372 1.8× 238 1.2× 178 1.9× 49 0.8× 55 1.0× 63 894
Jiafei Chen China 16 338 1.6× 161 0.8× 60 0.6× 43 0.7× 109 2.1× 37 689
Matthias Rübner Germany 13 164 0.8× 190 1.0× 146 1.6× 24 0.4× 20 0.4× 37 522
Luoquan Ao China 13 505 2.4× 248 1.3× 181 1.9× 23 0.4× 58 1.1× 22 765

Countries citing papers authored by Jiayi Zeng

Since Specialization
Citations

This map shows the geographic impact of Jiayi Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayi Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayi Zeng more than expected).

Fields of papers citing papers by Jiayi Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayi Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayi Zeng. The network helps show where Jiayi Zeng may publish in the future.

Co-authorship network of co-authors of Jiayi Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayi Zeng. A scholar is included among the top collaborators of Jiayi Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayi Zeng. Jiayi Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Jiayi, et al.. (2025). Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer. Frontiers in Oncology. 15. 1443571–1443571. 1 indexed citations
2.
Wang, Shun, Lan‐Ping Xu, Jiayi Zeng, et al.. (2025). The NET-DNA-CCDC25 inhibitor di-Pal-MTO suppresses tumor progression and promotes the innate immune response. Cellular and Molecular Immunology. 22(6). 628–644.
4.
Wang, Jinming, et al.. (2024). Achieving Sustainable Tourism: Analysis of the Impact of Environmental Education on Tourists’ Responsible Behavior. Sustainability. 16(2). 552–552. 7 indexed citations
5.
Zhang, Changzheng, et al.. (2024). Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma. Translational Cancer Research. 13(1). 150–172. 2 indexed citations
6.
Zeng, Jiayi & Zhong Han. (2024). YOLOv8-PD: an improved road damage detection algorithm based on YOLOv8n model. Scientific Reports. 14(1). 12052–12052. 27 indexed citations
8.
Zeng, Jiayi, et al.. (2023). Influence of Different pH and Clay Content on the Mechanical Properties of Red Clay. OALib. 10(10). 1–8. 1 indexed citations
10.
Yan, Jing‐Kun, Zhaoxia Li, Lingling Ding, et al.. (2022). ICH-LR2S2: a new risk score for predicting stroke-associated pneumonia from spontaneous intracerebral hemorrhage. Journal of Translational Medicine. 20(1). 193–193. 18 indexed citations
11.
12.
Zhang, Zedan, Yanjun Liu, Hongkai Zhuang, et al.. (2021). A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma. Journal of Immunology Research. 2021. 1–37. 12 indexed citations
13.
Zeng, Jiayi, et al.. (2021). Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas. Frontiers in Immunology. 12. 721830–721830. 63 indexed citations
14.
Wu, Xuan, Xue Cao, Meng Li, et al.. (2021). In vitro and in vitro toxicity study of diesel exhaust particles using BEAS-2B cell line and the nematode Caenorhabditis elegans as biological models. Environmental Science and Pollution Research. 28(43). 60704–60716. 7 indexed citations
15.
Zhang, Zedan, et al.. (2020). Identifying 4 Novel lncRNAs as Potential Biomarkers for Acute Rejection and Graft Loss of Renal Allograft. Journal of Immunology Research. 2020(1). 2415374–2415374. 12 indexed citations
16.
Chao, Xue, Kai Chen, Jiayi Zeng, et al.. (2019). Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis. BMC Cancer. 19(1). 372–372. 52 indexed citations
17.
Wu, Wei, Fei Chen, Xiuying Cui, et al.. (2018). LncRNA NKILA suppresses TGF‐β‐induced epithelial–mesenchymal transition by blocking NF‐κB signaling in breast cancer. International Journal of Cancer. 143(9). 2213–2224. 104 indexed citations
18.
Nie, Yan, Jianing Chen, Di Huang, et al.. (2017). Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation. Cancer Research. 77(13). 3605–3618. 43 indexed citations
19.
Yang, Xing, Qian Hu, Xiaorong Lin, et al.. (2017). miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.. PubMed. 24(131). 75–85. 55 indexed citations
20.
Han, Ping, Renhui Chen, Fang Wang, et al.. (2017). Novel chimeric transcript RRM2-c2orf48 promotes metastasis in nasopharyngeal carcinoma. Cell Death and Disease. 8(9). e3047–e3047. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026